Your session is about to expire
← Back to Search
Digital Mindfulness for Substance Use Disorder Recovery
N/A
Recruiting
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)
Awards & highlights
Study Summary
This trial tests a digital mindfulness-based treatment for people in early recovery from substance use, to see if it is effective & acceptable. Participants are randomized to usual treatment or usual+digital treatment over 8 weeks.
Who is the study for?
This trial is for adults over 18 who speak English, have finished at least one month of substance use disorder treatment, and used their primary substance within the last six months. They must not be in residential treatment, agree to random assignment, participate fully, provide contact info for follow-up, and own a smartphone with WIFI.Check my eligibility
What is being tested?
The study compares usual recovery treatments with an added digital mindfulness program completed over eight weeks. Participants are randomly placed into either the standard treatment group or the one that includes digital mindfulness exercises.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention (digital mindfulness), typical drug side effects are not expected. However, participants may experience emotional discomfort or distress related to mindfulness practice.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence to the digital treatment
Completion rates for ecological momentary assessment at baseline
Completion rates for ecological momentary assessment at post-treatment
+3 moreOther outcome measures
Change in frequency of any substance use
Change in frequency of primary substance use
Change in substance-related problems
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TAU Plus Digital Mindfulness-Based TreatmentExperimental Treatment2 Interventions
TAU consists of weekly outpatient-based group therapy. The digital mindfulness-based treatment is multimedia app-based program teaching mindfulness skills.
Group II: Treatment-as-Usual (TAU)Active Control1 Intervention
TAU consists of weekly outpatient-based group therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment-as-Usual (TAU)
2010
N/A
~510
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,853 Previous Clinical Trials
2,738,527 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
833 Previous Clinical Trials
669,419 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have thoughts of harming myself with a plan to do so.I am 18 years old or older.I can fluently speak and read English at a 6th grade level or higher.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment-as-Usual (TAU)
- Group 2: TAU Plus Digital Mindfulness-Based Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently accessible to individuals seeking treatment?
"Data hosted on clinicaltrials.gov demonstrates that this medical trial is open to recruitment, first posted on May 18th 2023 and updated as recently as the 19th of May."
Answered by AI
How many participants is the trial currently recruiting?
"Affirmative, clinicaltrials.gov reveals that this trial is still in need of applicants. Initially posted on May 18th 2023 and last updated the day after, it requires 34 individuals from one site to participate."
Answered by AI
Share this study with friends
Copy Link
Messenger